KRAS mutation in patients with metastatic colorectal cancer...

  • Main
  • 2014 / 02
  • KRAS mutation in patients with metastatic colorectal cancer...

KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin‑ or irinotecan‑based treatment

Soeda, Hiroshi, Shimodaira, Hideki, Watanabe, Mika, Suzuki, Takao, Gamo, Makio, Takahashi, Masanobu, Komine, Keigo, Kato, Shunsuke, Ishioka, Chikashi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular and Clinical Oncology
DOI:
10.3892/mco.2014.254
Date:
February, 2014
File:
PDF, 537 KB
english, 2014
Conversion to is in progress
Conversion to is failed